Original ArticlesMechanisms of Inhibition of the Thioredoxin Growth Factor System by Antitumor 2-Imidazolyl Disulfides
Section snippets
Preparation of Thioredoxins
Recombinant hTrx, Cys32 → Ser/Cys35 → Ser mutant hTrx (C32S/C35S) and Cys73 → Ser (C73S) mutant hTrx were prepared and purified as previously described 4, 10. Twenty-five micromolar stock solutions of the hTrxs in 5 mM of DTT were stored at −20°. Before use, the DTT was removed by passing the hTrx solution through a PD-10 desalting column (Pharmacia). The hTrx solution was kept at 4° and used fresh within 2 hr or hTrx was allowed to oxidize by keeping it at room temperature for at least 3 weeks
Cell Growth Inhibition
The effects of the disulfides on the growth of human MCF-7 breast cancer cells were studied (Fig. 1). The ic50 values of III-2 and IV-2 with 10% FBS were 35.0 and 3.2 μM, and in the presence of 1 μM of hTrx the ic50 values were 0.2 and 1.2 μM, respectively. We have found that C73S stimulates MCF-7 cell growth to the same extent as hTrx [4]; however, disulfides III-2 and IV-2 at 1 μM did not inhibit the cell growth caused by 1 μM of C73S (results not shown).
Interaction Between Disulfides and TR
Disulfides III-2 and VI-2 were
Discussion
The 2-imidazolyl disulfides interact with both TR and hTrx. It is postulated that the unbranched alkyl moieties of the disulfides III-2 and VI-2, both of which are substrates for TR, facilitate thiol/disulfide exchange with a Cys residue at the catalytic site of TR and the liberation of 2-mercaptoimidazole (Fig. 6A). There is a subsequent thiol/disulfide exchange to give an oxidized catalytic site followed by reduction by NADPH to regenerate the reduced enzyme. Branching of the alkyl
Acknowledgements
This work was supported by Grants CA 48725, and CA 42286 17094 (G. P.) and the University of Regina (D. L. K.).
References (26)
- et al.
Enzymatic synthesis of deoxyribonucleotides. VI. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B
J Biol Chem
(1964) Unfolding intermediates of the extracellular domain of the interferon γ receptor
J Biol Chem
(1992)- et al.
Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73 → Ser mutation
Biochem Pharmacol
(1996) - et al.
Reduced thioredoxinA possible physiological cofactor for vitamin K epoxide reductase. Futher support for an active site disulfide
Biochem Biophys Res Commun
(1988) - et al.
Oxidoreductive regulation of nuclear factor κBInvolvement of a cellular reducing catalyst thioredoxin
J Biol Chem
(1993) - et al.
Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin
J Biol Chem
(1983) - et al.
Human transcription factor IIIC (TFIIIC). Purification, polypeptide structure, and the involvement of thiol groups in specific DNA binding
J Biol Chem
(1989) - et al.
Site-directed mutagenesis of active site cysteines in human thioredoxin produces competitive inhibitors of human thioredoxin reductase and elimination of mitogenic properties of thioredoxin
J Biol Chem
(1994) - et al.
Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway
J Biol Chem
(1992) - et al.
The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF)Thioredoxin mRNA is elevated in some human tumors
Biochim Biophys Acta
(1994)